GABA transporter 1
      
GABA transporter 1 (GAT1) also known as sodium- and chloride-dependent GABA transporter 1 is a protein that in humans is encoded by the SLC6A1 gene.[1][2]
 Function 
GAT1 a gamma-aminobutyric acid (GABA) transporter, which removes GABA from the synaptic cleft.[3]
 Interactions 
SLC6A1 has been shown to interact with STX1A.[4][5][6]
 See also 
 References 
- ↑  Huang F, Shi LJ, Heng HH, Fei J, Guo LH (February 1996). "Assignment of the human GABA transporter gene (GABATHG) locus to chromosome 3p24-p25". Genomics 29 (1): 302–4. doi:10.1006/geno.1995.1253. PMID 8530094. 
- ↑  "Entrez Gene: SLC6A1 solute carrier family 6 (neurotransmitter transporter, GABA), member 1". 
- ↑  Hirunsatit R, George ED, Lipska BK, Elwafi HM, Sander L, Yrigollen CM, Gelernter J, Grigorenko EL, Lappalainen J, Mane S, Nairn AC, Kleinman JE, Simen AA (January 2009). "Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity". Pharmacogenet. Genomics 19 (1): 53–65. doi:10.1097/FPC.0b013e328318b21a. PMC 2791799. PMID 19077666. 
- ↑  Beckman ML, Bernstein EM, Quick MW (August 1998). "Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A". J. Neurosci. 18 (16): 6103–12. PMID 9698305. 
- ↑  Quick MW (April 2002). "Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner". Proc. Natl. Acad. Sci. U.S.A. 99 (8): 5686–91. doi:10.1073/pnas.082712899. PMC 122832. PMID 11960023. 
- ↑  Deken SL, Beckman ML, Boos L, Quick MW (October 2000). "Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A". Nat. Neurosci. 3 (10): 998–1003. doi:10.1038/79939. PMID 11017172. 
 
 Further reading 
- Nelson H, Mandiyan S, Nelson N (1990). "Cloning of the human brain GABA transporter.". FEBS Lett. 269 (1): 181–4. doi:10.1016/0014-5793(90)81149-I. PMID 2387399. 
- Bennett ER, Kanner BI (1997). "The membrane topology of GAT-1, a (Na+ + Cl-)-coupled gamma-aminobutyric acid transporter from rat brain.". J. Biol. Chem. 272 (2): 1203–10. doi:10.1074/jbc.272.2.1203. PMID 8995422. 
- Bismuth Y, Kavanaugh MP, Kanner BI (1997). "Tyrosine 140 of the gamma-aminobutyric acid transporter GAT-1 plays a critical role in neurotransmitter recognition.". J. Biol. Chem. 272 (26): 16096–102. doi:10.1074/jbc.272.26.16096. PMID 9195904. 
- DeFelipe J, González-Albo MC (1998). "Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex.". NeuroReport 9 (3): 467–70. doi:10.1097/00001756-199802160-00020. PMID 9512391. 
- Conti F, Melone M, De Biasi S, Minelli A, Brecha NC, Ducati A (1998). "Neuronal and glial localization of GAT-1, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex.". J. Comp. Neurol. 396 (1): 51–63. doi:10.1002/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H. PMID 9623887. 
- Beckman ML, Bernstein EM, Quick MW (1998). "Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A.". J. Neurosci. 18 (16): 6103–12. PMID 9698305. 
- Augood SJ, Waldvogel HJ, Münkle MC, Faull RL, Emson PC (1999). "Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus.". Neuroscience 88 (2): 521–34. doi:10.1016/S0306-4522(98)00226-7. PMID 10197772. 
- Ong WY, Yeo TT, Balcar VJ, Garey LJ (2000). "A light and electron microscopic study of GAT-1-positive cells in the cerebral cortex of man and monkey.". J. Neurocytol. 27 (10): 719–30. doi:10.1023/A:1006946717065. PMID 10640187. 
- Deken SL, Beckman ML, Boos L, Quick MW (2000). "Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A.". Nat. Neurosci. 3 (10): 998–1003. doi:10.1038/79939. PMID 11017172. 
- Whitworth TL, Quick MW (2001). "Substrate-induced regulation of gamma-aminobutyric acid transporter trafficking requires tyrosine phosphorylation.". J. Biol. Chem. 276 (46): 42932–7. doi:10.1074/jbc.M107638200. PMID 11555659. 
- Hachiya Y, Takashima S (2002). "Development of GABAergic neurons and their transporter in human temporal cortex.". Pediatr. Neurol. 25 (5): 390–6. doi:10.1016/S0887-8994(01)00348-4. PMID 11744314. 
- Quick MW (2002). "Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner.". Proc. Natl. Acad. Sci. U.S.A. 99 (8): 5686–91. doi:10.1073/pnas.082712899. PMC 122832. PMID 11960023. 
- Kanner BI (2003). "Transmembrane domain I of the gamma-aminobutyric acid transporter GAT-1 plays a crucial role in the transition between cation leak and transport modes.". J. Biol. Chem. 278 (6): 3705–12. doi:10.1074/jbc.M210525200. PMID 12446715. 
- Zomot E, Kanner BI (2003). "The interaction of the gamma-aminobutyric acid transporter GAT-1 with the neurotransmitter is selectively impaired by sulfhydryl modification of a conformationally sensitive cysteine residue engineered into extracellular loop IV.". J. Biol. Chem. 278 (44): 42950–8. doi:10.1074/jbc.M209307200. PMID 12925537. 
- Zhou Y, Bennett ER, Kanner BI (2004). "The aqueous accessibility in the external half of transmembrane domain I of the GABA transporter GAT-1 Is modulated by its ligands.". J. Biol. Chem. 279 (14): 13800–8. doi:10.1074/jbc.M311579200. PMID 14744863. 
- Hu JH, Ma YH, Jiang J, Yang N, Duan SH, Jiang ZH, Mei ZT, Fei J, Guo LH (2004). "Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1).". NeuroReport 15 (1): 9–12. doi:10.1097/00001756-200401190-00003. PMID 15106822. 
- Korkhov VM, Farhan H, Freissmuth M, Sitte HH (2005). "Oligomerization of the {gamma}-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II.". J. Biol. Chem. 279 (53): 55728–36. doi:10.1074/jbc.M409449200. PMID 15496410. 
 
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
| |  | 
|---|
 |  |  | Receptor (ligands)
 | |  | | Agonists |  | 
|---|
 |  |  | PAMs | 
  (abridged; see here for a full list): α-EMTBL Alcohols (e.g., ethanol) Avermectins (e.g., ivermectin) Barbiturates (e.g., phenobarbital) Benzodiazepines (e.g., diazepam) Bromide compounds (e.g., potassium bromide) Carbamates (e.g., meprobamate) Carbamazepine Chloralose Chlormezanone Clomethiazole Dihydroergolines (e.g., ergoloid (dihydroergotoxine)) Etazepine Etifoxine Fenamates (e.g., mefenamic acid) Flavonoids (e.g., apigenin, hispidulin) Fluoxetine Flupirtine Imidazoles (e.g., etomidate) Kava constituents (e.g., kavain) Lanthanum Loreclezole Monastrol Neuroactive steroids (e.g., allopregnanolone, cholesterol) Niacin Nicotinamide (niacinamide) Nonbenzodiazepines (e.g., β-carbolines (e.g., abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon)) Norfluoxetine Petrichloral Phenols (e.g., propofol) Phenytoin Piperidinediones (e.g., glutethimide) Propanidid Pyrazolopyridines (e.g., etazolate) Quinazolinones (e.g., methaqualone) Retigabine (ezogabine) ROD-188 Skullcap constituents (e.g., baicalin) Stiripentol Sulfonylalkanes (e.g., sulfonmethane (sulfonal)) Topiramate Valerian constituents (e.g., valerenic acid) Volatiles/gases (e.g., chloral hydrate, chloroform, diethyl ether, paraldehyde, sevoflurane)
 | 
|---|
 |  |  | Antagonists |  | 
|---|
 |  |  | NAMs | 
 1,3M1B 3M2B 17-Phenylandrostenol α5IA (LS-193,268) β-CCB β-CCE β-CCM β-CCP β-EMGBL Amiloride Anisatin β-Lactams (e.g., penicillins, cephalosporins, carbapenems) Basmisanil Bemegride Bilobalide CHEB Cicutoxin Cloflubicyne Cyclothiazide DHEA DHEA-S Dieldrin (+)-DMBB DMCM DMPC EBOB Etbicyphat FG-7142 (ZK-31906) Fiproles (e.g., fipronil) Flavonoids (e.g., amentoflavone, oroxylin A) Flumazenil Fluoroquinolones (e.g., ciprofloxacin) Flurothyl Furosemide Iomazenil (123I) Isoallopregnanolone Isopregnanolone (sepranolone) L-655,708 Laudanosine Leptazol Lindane MaxiPost Morphine Morphine-3-glucuronide MRK-016 Naloxone Naltrexone Nicardipine Non-steroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide) Oenanthotoxin Pentetrazol (metrazol) Phenylsilatrane Picrotoxin (i.e., picrotin and picrotoxinin) Pregnenolone sulfate Propybicyphat PWZ-029 Radequinil Ro 15-4513 Ro 19-4603 RO4882224 RO4938581 Sarmazenil SCS Suritozole TB-21007 TBOB TBPS TCS-1105 Terbequinil TETS Thujone U-93631 Zinc ZK-93426
 | 
|---|
 | 
|---|
 |  |  |  | | Agonists |  | 
|---|
 |  |  | PAMs |  | 
|---|
 |  |  | Antagonists |  | 
|---|
 |  |  | NAMs |  | 
|---|
 | 
|---|
 |  |  |  | | Agonists |  | 
|---|
 |  |  | Antagonists |  | 
|---|
 |  |  | NAMs |  | 
|---|
 |  |  | PAMs |  | 
|---|
 | 
|---|
 | 
|---|
 |  |  | Transporter (blockers)
 |  | 
|---|
 |  |  | Enzyme (inhibitors)
 |  | 
|---|
 |  |  | Others | | Precursors |  | 
|---|
 |  |  | Analogues |  | 
|---|
 |  |  | Others |  | 
|---|
 | 
|---|
 |  |  | See also: GHBergics • Glutamatergics • Glycinergics | 
 | 
| |  | 
|---|
 |  |  | | By group | 
|---|
 |  |  | | | SLC1–10 | 
|---|
 |  |  | | (1): |  | 
|---|
 |  |  | (2): |  | 
|---|
 |  |  | (3): |  | 
|---|
 |  |  | (4): |  | 
|---|
 |  |  | (5): |  | 
|---|
 |  |  | (6): |  | 
|---|
 |  |  | (7): |  | 
|---|
 |  |  | (8): |  | 
|---|
 |  |  | (9): |  | 
|---|
 |  |  | (10): |  | 
|---|
 | 
 |  |  |  | | SLC11–20 | 
|---|
 |  |  | | (11): | 
 proton coupled metal ion transporter
 | 
|---|
 |  |  | (12): |  | 
|---|
 |  |  | (13): | 
 human Na+-sulfate/carboxylate cotransporter
 | 
|---|
 |  |  | (14): |  | 
|---|
 |  |  | (15): | 
 proton oligopeptide cotransporter
 | 
|---|
 |  |  | (16): | 
 monocarboxylate transporter
 | 
|---|
 |  |  | (17): |  | 
|---|
 |  |  | (18): |  | 
|---|
 |  |  | (19): |  | 
|---|
 |  |  | (20): |  | 
|---|
 | 
 |  |  |  | | SLC21–30 | 
|---|
 |  |  | | (21): |  | 
|---|
 |  |  | (22): |  | 
|---|
 |  |  | (23): | 
 Na+-dependent ascorbic acid transporter
 | 
|---|
 |  |  | (24): |  | 
|---|
 |  |  | (25): |  | 
|---|
 |  |  | (26): | 
 multifunctional anion exchanger
 | 
|---|
 |  |  | (27): |  | 
|---|
 |  |  | (28): | 
 Na+-coupled nucleoside transport (SLC28A1
 | 
|---|
 |  |  | (29): | 
 facilitative nucleoside transporter
 | 
|---|
 |  |  | (30): |  | 
|---|
 | 
 |  |  |  | | SLC31–40 | 
|---|
 |  |  | | (31): |  | 
|---|
 |  |  | (32): |  | 
|---|
 |  |  | (33): |  | 
|---|
 |  |  | (34): | 
 type II Na+-phosphate cotransporter
 | 
|---|
 |  |  | (35): | 
 nucleoside-sugar transporter
 SLC35E1 SLC35E2 SLC35E3 SLC35E4
 | 
|---|
 |  |  | (36): | 
 proton-coupled amino-acid transporter
 | 
|---|
 |  |  | (37): | 
 sugar-phosphate/phosphate exchanger
 | 
|---|
 |  |  | (38): | 
 System A & N, sodium-coupled neutral amino-acid transporter
 | 
|---|
 |  |  | (39): |  | 
|---|
 |  |  | (40): | 
 basolateral iron transporter
 | 
|---|
 | 
 |  |  |  | | SLC41–48 | 
|---|
 |  |  | | (41): |  | 
|---|
 |  |  | (42): |  | 
|---|
 |  |  | (43): | 
 Na+-independent, system-L like amino-acid transporter
 | 
|---|
 |  |  | (44): |  | 
|---|
 |  |  | (45): | 
 Putative sugar transporter
 | 
|---|
 |  |  | (46): |  | 
|---|
 |  |  | (47): |  | 
|---|
 |  |  | (48): |  | 
|---|
 | 
 |  |  |  |  | 
 | 
 |  |  |  |  |  |  |  | see also solute carrier disorders | 
 |